CHAIYAPON COUROPMITREE, M.D.; NORBERT FREINKEL, M.D., F.A.C.P.; THEODORE C. NAGEL, M.D.; DAVID L. HORWITZ, M.D.; BOYD METZGER, M.D.; ARTHUR H. RUBENSTEIN, M.D., F.A.C.P.; ROBERT HAHNEL, M.D.
Factitious hyperinsulinism was suspected in a patient with an 11-year history of insulin-dependent, ketosis-prone diabetes mellitus who began to experience repetitive episodes of "spontaneous" hypoglycemia. Insulin mediation of the hypoglycemia was confirmed by documenting that urinary insulin and total extractable insulin in plasma increased during periods of hypoglycemia. Failure to detect significant amounts of human C-peptide by radioimmunoassay during periods of hypoglycemia or in response to stimulation with glucagon, leucine, or tolbutamide indicated that the insulin was not endogenous. The diagnosis of factitious hyperinsulinism was ultimately proved by the finding of radioactivity in the patient's urine after 131I Hippuran® was added to a vial of insulin found in the patient's room.
COUROPMITREE C, FREINKEL N, NAGEL TC, HORWITZ DL, METZGER B, RUBENSTEIN AH, et al. Plasma C-Peptide and Diagnosis of Factitious Hyperinsulinism: Study of an Insulin-Dependent Diabetic Patient with "Spontaneous" Hypoglycemia. Ann Intern Med. ;82:201–204. doi: 10.7326/0003-4819-82-2-201
Download citation file:
Published: Ann Intern Med. 1975;82(2):201-204.
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use